The changes in expression of both Cyclin D2 and G0S2 indicate that the p53-haploinsufficient stromal cells have a substantial disruption of normal cell cycle progression, which suggests a role for these cells in breast tissue growth and therefore on cancer predisposition of LFS patients. The gene discussed is TP53; the disease is cancer.